rs768579561
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001099404.2(SCN5A):c.3963+1G>A variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000688 in 1,453,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001099404.2 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_000335.5 | c.3960+1G>A | splice_donor_variant | ENST00000423572.7 | NP_000326.2 | |||
SCN5A | NM_001099404.2 | c.3963+1G>A | splice_donor_variant | ENST00000413689.6 | NP_001092874.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.3963+1G>A | splice_donor_variant | 5 | NM_001099404.2 | ENSP00000410257 | P4 | |||
SCN5A | ENST00000423572.7 | c.3960+1G>A | splice_donor_variant | 1 | NM_000335.5 | ENSP00000398266 | A1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000427 AC: 1AN: 234370Hom.: 0 AF XY: 0.00000787 AC XY: 1AN XY: 126996
GnomAD4 exome AF: 6.88e-7 AC: 1AN: 1453920Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 722306
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 11, 2023 | Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 132906). This sequence change affects a donor splice site in intron 22 of the SCN5A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SCN5A are known to be pathogenic (PMID: 20129283, 22789973). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. Disruption of this splice site has been observed in individuals with SCN5A-related conditions (PMID: 10471492, 20031634, 24972929, 28341781). - |
Likely pathogenic, no assertion criteria provided | literature only | Institute for Genetics of Heart Diseases, University Hospital Muenster | - | - - |
Brugada syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 10, 2014 | The 3963+1G>A variant in SCN5A had not been reported in individuals with cardiom yopathy, Brugada, or Long QT syndrome and data from large population studies is insufficient to assess the frequency of this variant. This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and is predicted to cause altered splicing leading to an abnormal or absent protein. Another varian t as this splice junction (3963+2T>C) has been reported in 2 large families, 1 w ith PCCD and 1 with PCCD and Brugada, and segregated with disease in >20 affecte d relatives (Schott 1999, Probst 2009, Gourraud 2012). Splice and truncating var iants are well-reported in individuals with Brugada syndrome (Human Gene Mutatio n Database). In summary, the predicted impact of this variant supports that it i s likely to be pathogenic, though additional studies are required to fully estab lish its clinical significance. - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 02, 2018 | The c.3963+1G>A intronic variant results from a G to A substitution one nucleotide after coding exon 21 of the SCN5A gene. This alteration has been reported in association with varying arrhythmias, including an individual with progressive cardiac conduction disease (PCCD) and ventricular fibrillation, and has also been detected in a Brugada syndrome (BrS) cohort; however, clinical details were limited (Friedrich C et al. EMBO Mol Med. 2014;6:937-51; Yamagata K et al. Circulation. 2017;135:2255-2270 (reported as IVS23+1G>A)). Another alteration affecting this splice site (c.3963+2T>C) has also been reported in association with PCCD and BrS (Probst V et al. J Am Coll Cardiol. 2003;41:643-52; Probst V et al. Circ Cardiovasc Genet. 2009;2:552-7). This nucleotide position is highly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to abolish the native splice donor site; however, direct evidence is unavailable. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at